These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 1335650

  • 1. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile.
    Riedemann S, Reinhardt G, Frösner GG, Ibarra H, Moraleda L, Hering V, Siegel F, Toledo C, Leon J, Gonzalez JL.
    Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650
    [Abstract] [Full Text] [Related]

  • 2. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P, Van Gerven V, Safary A, Delem A, Knops J, D'Hondt E, André FE, Desmyter J.
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [Abstract] [Full Text] [Related]

  • 3. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.
    André FE, D'Hondt E, Delem A, Safary A.
    Vaccine; 1992; 10 Suppl 1():S160-8. PubMed ID: 1335652
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous vaccination against hepatitis A and B: results of a controlled study.
    Ambrosch F, André FE, Delem A, D'Hondt E, Jonas S, Kunz C, Safary A, Wiedermann G.
    Vaccine; 1992; 10 Suppl 1():S142-5. PubMed ID: 1335647
    [Abstract] [Full Text] [Related]

  • 5. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L, Kallinowski B, Gmelin K, Hofmann F, Scheiermann N, Wohland B, Stickl H, Maiwald H, Moriabadi FK, Bock HL.
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [Abstract] [Full Text] [Related]

  • 6. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M, Berger R.
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [Abstract] [Full Text] [Related]

  • 7. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G, Yalçin SS, Ceyhan M, Yurdakök K.
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL, Leentvaar-Kuijpers A, Rotman H, Lelie PN.
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [Abstract] [Full Text] [Related]

  • 9. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A.
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis A vaccination: schedule for accelerated immunization.
    Müller R, Chriske H, Deinhardt F, Jilg J, Theilmann L, Hess G, Hofmann F, Hopf U, Stickl H, Maiwald H.
    Vaccine; 1992 Dec; 10 Suppl 1():S124-5. PubMed ID: 1335641
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.
    Newcomer W, Rivin B, Reid R, Moulton LH, Wolff M, Croll J, Johnson C, Brown L, Nalin D, Santosham M.
    Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954
    [Abstract] [Full Text] [Related]

  • 12. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D, Ashur Y, Adler R, Lewis JA, Armstrong ME, Davide JP, McGuire B, Kuter B, Brown L, Miller W.
    Vaccine; 1993 Jul; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [Abstract] [Full Text] [Related]

  • 13. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.
    Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G.
    N Engl J Med; 1992 Aug 13; 327(7):453-7. PubMed ID: 1320740
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E, Xueref C, Blondeau C, Bajard A, Francon A, Goudeau A, Peyron F, Brasseur P, Zuckerman A.
    Biologicals; 1996 Sep 13; 24(3):235-42. PubMed ID: 8978923
    [Abstract] [Full Text] [Related]

  • 15. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
    Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Zur S, Slepon R, Robin G, Hoke C, Bancroft W.
    Isr J Med Sci; 1994 Sep 13; 30(5-6):485-8. PubMed ID: 8034508
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers.
    Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS.
    J Gastroenterol Hepatol; 1993 Sep 13; 8(4):338-41. PubMed ID: 8397010
    [Abstract] [Full Text] [Related]

  • 17. Vaccination against hepatitis A: comparison of different short-term immunization schedules.
    Jilg W, Bittner R, Bock HL, Clemens R, Schätzl H, Schmidt M, André FE, Deinhardt F.
    Vaccine; 1992 Sep 13; 10 Suppl 1():S126-8. PubMed ID: 1335642
    [Abstract] [Full Text] [Related]

  • 18. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ, Palmer SJ, Barrow S, Perry KR, Tyrell H, Safary A, Banatvala JE.
    Vaccine; 1992 Sep 13; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [Abstract] [Full Text] [Related]

  • 19. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules.
    Troisi CL, Hollinger FB, Krause DS, Pickering LK.
    Vaccine; 1997 Oct 13; 15(15):1613-7. PubMed ID: 9364691
    [Abstract] [Full Text] [Related]

  • 20. Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.
    Maiwald H, Jilg W, Bock HL, Löscher T, Sonnenburg F.
    Vaccine; 1997 Mar 13; 15(4):346-8. PubMed ID: 9141202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.